Plain-English translation of NCT06842875 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a technology-based program called RI-SPHERES that helps postpartum people monitor their blood pressure at home using a smart cuff that connects to a smartphone app. The app sends you reminders to check your blood pressure and gives you personalized messages based on your readings. The study wants to see whether this approach helps prevent serious complications from pregnancy-related high blood pressure and makes it easier for people to get the preventive care they need.
Pregnancy-related high blood pressure is a serious condition that can cause lasting health problems or even be life-threatening if not managed well. Many people miss follow-up appointments after delivery because of childcare or transportation challenges, and these problems are especially common in communities of color. This trial is testing whether a convenient home monitoring system can help more people stay safe and connected to care, especially those who find it hardest to get to appointments.
You likely qualify if…
You likely don't qualify if…
If you join the new RI-SPHERES program, you'll receive a special blood pressure cuff that wirelessly connects to an app on your smartphone. For the first six weeks, you'll measure your blood pressure regularly at home, and the app will send you reminders and messages tailored to your readings. After six weeks, the program shifts to help you transition to ongoing preventive care with your regular doctor over the next several months. A nurse and care team will monitor your progress and work together to make sure you get the support you need.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
United States